Literature DB >> 21790671

Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats.

Annayya R Aroor1, Daniel E Jackson, Shivendra D Shukla.   

Abstract

BACKGROUND: Binge drinking after chronic ethanol consumption is one of the important factors contributing to the progression of steatosis to steatohepatitis. The molecular mechanisms of this effect remain poorly understood. We have therefore examined in rats the effect of single and repeat ethanol binge superimposed on chronic ethanol intake on liver injury, activation of mitogen-activated protein kinases (MAPKs), and gene expression.
METHODS: Rats were chronically treated with ethanol in liquid diet for 4 weeks followed by single ethanol binge (5 gm/kg body weight) or 3 similar repeated doses of ethanol. Serum alcohol and alanine amino transferase (ALT) levels were determined by enzymatic methods. Steatosis was assessed by histology and hepatic triglycerides. Activation of MAPK, 90S ribosomal kinase (RSK), and caspase 3 were evaluated by Western blot. Levels of mRNA for tumor necrosis factor alpha (TNFα), early growth response-1 (egr-1), and plasminogen activator inhibitor-1 (PAI-1) were measured by real-time qRT-PCR.
RESULTS: Chronic ethanol treatment resulted in mild steatosis and necrosis, whereas chronic ethanol followed by binge group exhibited marked steatosis and significant increase in necrosis. Chronic binge group also showed significant increase (compared with chronic ethanol alone) in the phosphorylation of extracellular regulated kinase 1 (ERK1), ERK2, and RSK. Phosphorylation of c-Jun N-terminal kinase (JNK) and p38 MAPK did not increase by the binge. Ethanol binge, after chronic ethanol intake, caused increase in mRNA for egr-1 and PAI-1, but not TNFα.
CONCLUSIONS: Chronic ethanol exposure increases the susceptibility of rat liver to increased injury by 1 or 3 repeat binge. Among other alterations, the activated levels of ERK1, and more so ERK2, were remarkably amplified by binge suggesting a role of these isotypes in the binge amplification of the injury. In contrast, p38 MAPK and JNK1/2 activities were not amplified. These binge-induced changes were also reflected in the increases in the RNA levels for egr-1 and PAI-1. This study offers chronic followed by repeat binge as a model for the study of progression of liver injury by ethanol and highlights the involvement of ERK1 and ERK2 isotypes in the amplification of liver injury by binge ethanol.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21790671      PMCID: PMC3204341          DOI: 10.1111/j.1530-0277.2011.01577.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  56 in total

1.  Effect of binge drinking on the liver: an alarming public health issue?

Authors:  Philippe Mathurin; Pierre Deltenre
Journal:  Gut       Date:  2009-01-27       Impact factor: 23.059

2.  Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation.

Authors:  Ayman Koteish; ShiQi Yang; HuiZhi Lin; Xiawen Huang; Anna Mae Diehl
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

3.  Up-regulation of CD14 in liver caused by acute ethanol involves oxidant-dependent AP-1 pathway.

Authors:  Michael D Wheeler; Ronald G Thurman
Journal:  J Biol Chem       Date:  2002-12-13       Impact factor: 5.157

4.  Phosphotidylethanol mimics ethanol modulation of p42/44 mitogen-activated protein kinase signalling in hepatocytes.

Authors:  Annayya R Aroor; Geoffrey W Custer; Yu-I Weng; Youn Ju Lee; Shivendra D Shukla
Journal:  Alcohol Alcohol       Date:  2002 Nov-Dec       Impact factor: 2.826

5.  p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis.

Authors:  Yan Xiong; Qu Fan Collins; Jie An; Edgar Lupo; Hui-Yu Liu; Delong Liu; Jacques Robidoux; Zhenqi Liu; Wenhong Cao
Journal:  J Biol Chem       Date:  2006-12-17       Impact factor: 5.157

Review 6.  Clinical syndromes of alcoholic liver disease.

Authors:  Masayuki Adachi; David A Brenner
Journal:  Dig Dis       Date:  2005       Impact factor: 2.404

7.  Involvement of tumor necrosis factor alpha, rather than interleukin-1alpha/beta or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver.

Authors:  Takiko Oguro; Yuko Takahashi; Takashi Ashino; Atsushi Takaki; Seiji Shioda; Reiko Horai; Masahide Asano; Kenji Sekikawa; Yoichiro Iwakura; Takemi Yoshida
Journal:  FEBS Lett       Date:  2002-04-10       Impact factor: 4.124

8.  Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats.

Authors:  Michael K H Hsu; Liang Qiao; Vikki Ho; Bao-Hong Zhang; Hongxia Zhang; Narci Teoh; Paul Dent; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2005-08-26       Impact factor: 25.083

9.  Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice.

Authors:  Juliane I Beier; James P Luyendyk; Luping Guo; Claudia von Montfort; Donald E Staunton; Gavin E Arteel
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 10.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

View more
  21 in total

1.  Binge Alcohol Is More Injurious to Liver in Female than in Male Rats: Histopathological, Pharmacologic, and Epigenetic Profiles.

Authors:  Shivendra D Shukla; Ricardo Restrepo; Annayya R Aroor; Xuanyou Liu; Robert W Lim; Jacob D Franke; David A Ford; Ronald J Korthuis
Journal:  J Pharmacol Exp Ther       Date:  2019-07-01       Impact factor: 4.030

Review 2.  Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

Authors:  Alex Boye; Yu-Hong Zou; Yan Yang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression.

Authors:  Annayya R Aroor; Shivendra D Shukla
Journal:  World J Hepatol       Date:  2011-09-27

4.  Therapeutic Benefits of Spleen Tyrosine Kinase Inhibitor Administration on Binge Drinking-Induced Alcoholic Liver Injury, Steatosis, and Inflammation in Mice.

Authors:  Terence N Bukong; Arvin Iracheta-Vellve; Benedek Gyongyosi; Aditya Ambade; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2016-05-14       Impact factor: 3.455

5.  Transgenic expression of carbonic anhydrase III in cardiac muscle demonstrates a mechanism to tolerate acidosis.

Authors:  Han-Zhong Feng; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-07       Impact factor: 4.249

6.  Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

Authors:  Annayya R Aroor; Ricardo J Restrepo; Kusum K Kharbanda; Shivendra D Shukla
Journal:  Hepatol Int       Date:  2014-06-18       Impact factor: 6.047

7.  Binge alcohol alters PNPLA3 levels in liver through epigenetic mechanism involving histone H3 acetylation.

Authors:  Ricardo J Restrepo; Robert W Lim; Ronald J Korthuis; Shivendra D Shukla
Journal:  Alcohol       Date:  2017-03-12       Impact factor: 2.405

8.  Mouse model of chronic and binge ethanol feeding (the NIAAA model).

Authors:  Adeline Bertola; Stephanie Mathews; Sung Hwan Ki; Hua Wang; Bin Gao
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

Review 9.  Rodent models of alcoholic liver disease: of mice and men.

Authors:  Elizabeth Brandon-Warner; Laura W Schrum; C Max Schmidt; Iain H McKillop
Journal:  Alcohol       Date:  2012-09-07       Impact factor: 2.405

Review 10.  Binge ethanol and liver: new molecular developments.

Authors:  Shivendra D Shukla; Stephen B Pruett; Gyongyi Szabo; Gavin E Arteel
Journal:  Alcohol Clin Exp Res       Date:  2013-01-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.